Economic Perspective on Diagnosis and Treatment of Endometriosis
Endometriosis incurs significant societal costs due to diagnostic delays, chronic treatment needs, and lost productivity, underscoring the need for cost-effective diagnostic and treatment research.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (27)
- A cost-effective approach to the management of endometriosis via openalex
- Actuarial analysis of private payer administrative claims data for women with endometriosis via openalex
- An economically rational method of managing early-stage endometriosis via openalex
- Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates via openalex
- Cost comparisons between nafarelin and leuprolide in the treatment of endometriosis via openalex
- Diagnosis and treatment of endometriosis via openalex
- Diagnostic accuracy of physical examination, transvaginal sonography, rectal endoscopic sonography, and magnetic resonance imaging to diagnose deep infiltrating endometriosis via openalex
- Diagnostic delay in women with pain and endometriosis via openalex
- Economic burden of endometriosis via openalex
- Endometriosis: cost estimates and methodological perspective via openalex
- Endoscopic treatment of endometriosis-associated infertility. Therapeutic, economic and social benefits via openalex
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- Evaluation of Lovelace Health Systems chronic pelvic pain protocol via openalex
- Human issues and medical economics of endometriosis. Three- vs. six-month GnRH-agonist therapy via openalex
- Is helium thermal coagulator therapy for the treatment of women with minimal to moderate endometriosis cost-effective? A prospective randomised controlled trial via openalex
- Modeling of medical and surgical treatment costs of chronic pelvic pain: new paradigms for making clinical decisions via openalex
- Modified ultrasound scanning is a cost-effective method for the detection of deep infiltrating endometriosis via openalex
- Pelvic endometriosis: impact of magnetic resonance imaging on treatment decisions and costs via openalex
- The clinical and economic benefits of GnRH agonist in treating endometriosis via openalex
- The cost of inpatient endometriosis treatment: an analysis based on the Healthcare Cost and Utilization Project Nationwide Inpatient Sample via openalex
- The Cost of Treatment of Endometriosis in the California Medicaid Population via openalex
- Time elapsed from onset of symptoms to diagnosis of endometriosis in a cohort study of Brazilian women via openalex
- W6706599912 via openalex
- W2083325871 via openalex
- W2135863583 via openalex
- W3151002452 via openalex
- W6679867864 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00